273 related articles for article (PubMed ID: 26639195)
1. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
Ye L; Jiang WG
Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review).
Sun Z; Cai S; Zabkiewicz C; Liu C; Ye L
Int J Oncol; 2020 Jun; 56(6):1335-1351. PubMed ID: 32236571
[TBL] [Abstract][Full Text] [Related]
3. Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?
Ehata S; Yokoyama Y; Takahashi K; Miyazono K
Pathol Int; 2013 Jun; 63(6):287-96. PubMed ID: 23782330
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
5. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
Gacche RN; Meshram RJ
Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
Jiramongkolchai P; Owens P; Hong CC
Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review).
Ye L; Bokobza SM; Jiang WG
Int J Mol Med; 2009 Nov; 24(5):591-7. PubMed ID: 19787192
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis.
Raida M; Clement JH; Leek RD; Ameri K; Bicknell R; Niederwieser D; Harris AL
J Cancer Res Clin Oncol; 2005 Nov; 131(11):741-50. PubMed ID: 16136355
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of tumor neovascularization.
Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
[TBL] [Abstract][Full Text] [Related]
13. Important signals regulating coronary artery angiogenesis.
Shoeibi S; Mozdziak P; Mohammadi S
Microvasc Res; 2018 May; 117():1-9. PubMed ID: 29247718
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
Cao Y; Liu Q
Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein and bone metastasis, implication and therapeutic potential.
Ye L; Mason MD; Jiang WG
Front Biosci (Landmark Ed); 2011 Jan; 16(3):865-97. PubMed ID: 21196208
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells and their vascular niche: Do they benefit from each other?
Ping YF; Zhang X; Bian XW
Cancer Lett; 2016 Oct; 380(2):561-567. PubMed ID: 25979233
[TBL] [Abstract][Full Text] [Related]
17. Dual targeting of vascular endothelial growth factor and bone morphogenetic protein-9/10 impairs tumor growth through inhibition of angiogenesis.
Akatsu Y; Yoshimatsu Y; Tomizawa T; Takahashi K; Katsura A; Miyazono K; Watabe T
Cancer Sci; 2017 Jan; 108(1):151-155. PubMed ID: 28133920
[TBL] [Abstract][Full Text] [Related]
18. Catecholamines regulate tumor angiogenesis.
Chakroborty D; Sarkar C; Basu B; Dasgupta PS; Basu S
Cancer Res; 2009 May; 69(9):3727-30. PubMed ID: 19383906
[TBL] [Abstract][Full Text] [Related]
19. Editorial foreword special issue: "Angiogenesis-convergent or divergent, that is the question: Research toward targeted strategies in oncology".
Cai J
Cancer Lett; 2016 Oct; 380(2):523-524. PubMed ID: 27032878
[No Abstract] [Full Text] [Related]
20. Bone morphogenetic proteins and their receptor signaling in prostate cancer.
Ye L; Lewis-Russell JM; Kyanaston HG; Jiang WG
Histol Histopathol; 2007 Oct; 22(10):1129-47. PubMed ID: 17616940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]